BioNTech Financials
| 22UA Stock | 113.80 2.90 2.61% |
BioNTech |
Understanding current and past BioNTech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioNTech's financial statements are interrelated, with each one affecting the others. For example, an increase in BioNTech's assets may result in an increase in income on the income statement.
Please note, the presentation of BioNTech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioNTech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioNTech's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | US09075V1026 |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
You should never invest in BioNTech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioNTech Stock, because this is throwing your money away. Analyzing the key information contained in BioNTech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioNTech Key Financial Ratios
There are many critical financial ratios that BioNTech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioNTech SE reports annually and quarterly.BioNTech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioNTech's current stock value. Our valuation model uses many indicators to compare BioNTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioNTech competition to find correlations between indicators driving BioNTech's intrinsic value. More Info.BioNTech SE is the top company in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for BioNTech SE is about 12,844,042,217 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioNTech's earnings, one of the primary drivers of an investment's value.BioNTech SE Systematic Risk
BioNTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioNTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on BioNTech SE correlated with the market. If Beta is less than 0 BioNTech generally moves in the opposite direction as compared to the market. If BioNTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioNTech SE is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioNTech is generally in the same direction as the market. If Beta > 1 BioNTech moves generally in the same direction as, but more than the movement of the benchmark.
BioNTech Thematic Clasifications
BioNTech SE is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
BioNTech November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioNTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioNTech SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioNTech SE based on widely used predictive technical indicators. In general, we focus on analyzing BioNTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioNTech's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.22 | |||
| Information Ratio | 0.1161 | |||
| Maximum Drawdown | 29.21 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 7.27 |
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |